Japan’s Rejection Of Foreign Trial Data Continues To Harry Newcomers
This article was originally published in The Gray Sheet
Executive Summary
Small and mid-size device companies seeking product approval in Japan will encounter resistance to international trial data, according to Pacific Bridge Medical (PBM) President Ames Gross
You may also be interested in...
Japan Promises To Wipe Application Backlog, Embrace Foreign Data In 2006
Japan vows to eliminate its backlog of device applications by October in a June 29 report on regulatory reform efforts in the U.S. and Japan
Japan Promises To Wipe Application Backlog, Embrace Foreign Data In 2006
Japan vows to eliminate its backlog of device applications by October in a June 29 report on regulatory reform efforts in the U.S. and Japan
BSD Medical Plans To File PMA For Cancer Therapy, Prepares Japanese Strategy
BSD Medical plans to submit a PMA application by the end of the quarter for its non-invasive BSD-2000 tumor hyperthermia therapy system to treat cancer